Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TMO stock price vs L: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at L's multiple
Needs L P/E.
Implied fair value · at TMO's multiple
Needs Annual EPS, TMO P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
THERMO FISHER SCIENTIFIC INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
LOEWS CORP · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
L · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Agilent Technologies, Inc.
TMO vs A
DANAHER CORP /DE/
TMO vs DHR
Illumina, Inc.
TMO vs ILMN
BRUKER CORP
TMO vs BRKR
BERKSHIRE HATHAWAY INC
TMO vs BRK-B
MARKEL GROUP INC.
TMO vs MKL
CNA FINANCIAL CORP
TMO vs CNA
AMERICAN INTERNATIONAL GROUP, INC.
TMO vs AIG
GENERAL ELECTRIC CO
TMO vs GE
3M CO
TMO vs MMM
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TMO can sustain a premium valuation through continued margin strength and better growth than the current 3.9% revenue pace, then hold or selectively accumulate, because the data shows superior profitability and ROIC but the stock already prices in a lot of that quality.
TMO trades well above L on P/E, P/S, EV/EBITDA, and EV/Revenue, yet the supplied DCF range still sits far below the current price. The valuation gap is driven by TMO’s richer quality profile and higher margins, but the implied downside to the DCF and P/E-based value suggests the stock is priced for sustained outperformance.
Supporting Metrics
